| abstract |
Methods and compositions are described herein that involve the use of proteins having kynurenase activity, for example, in certain aspects, may be modified kynurenases that are capable of degrading kynurenine are disclosed. Furthermore, certain aspects of the invention provide compositions and methods for treating kynurenine-depleted cancers using the disclosed proteins or nucleic acids. |